Dr. Kathleen Sakamoto, MD
Palo Alto, CA
34 Years of Experience
Affiliated with a Castle Connolly Top Hospital
Who is Dr. Sakamoto, Pediatric Hematologist-Oncologist in Palo Alto, CA?
Castle Connolly Top Doctor
Castle Connolly Top Doctors are doctor-nominated and selected by a physician-led research team.
What are Areas of Expertise for Dr. Sakamoto?
Dr. Kathleen Sakamoto, MD is a highly-rated, board-certified Pediatric Hematologist-Oncologist known for expertly diagnosing, treating, and managing a wide array of related conditions and procedures. Utilizing the latest medical advancements and evidence-based practices, Dr. Sakamoto empowers patients to confidently navigate their health journey, specializing in Bone Marrow Transplant, Leukemia, Pediatric Cancers, and comprehensive wellness support. Serving the Palo Alto, CA community, Dr. Sakamoto is dedicated to enhancing lives through expert, patient-centered care.
Where did Dr. Sakamoto go to medical school and complete their residency?
Is Dr. Sakamoto board certified as a Pediatric Hematologist-Oncologist?
Yes, Dr. Kathleen Sakamoto, MD is board certified by the American Board of Pediatrics
What languages does Dr. Sakamoto speak?
Dr. Sakamoto and their clinical team can communicate with patients in the following languages:
- English
- Spanish
What conditions does a Pediatric Hematologist-Oncologist like Dr. Sakamoto typically treat?
As a Pediatric Hematologist-Oncologist, Dr. Sakamoto diagnoses, treats, and manages a wide range of conditions. This condition information is derived from anonymized insurance claims and highlights the medical conditions most commonly treated by Dr. Sakamoto. It provides insight into the doctor’s areas of experience and expertise based on real-world patient encounters from the past two years, updated quarterly. Learn more about our claims-based healthcare methodology.
Also known as:
- Acute Lymphoblastic Leukemia
- Acute Lymphocytic Leukemia in Remission
- Chronic Myeloid Leukemia
- Acute Lymphocytic Leukemia
- Chronic Myelogenous Leukemia Treatment (PDQ®)
- ALL
- Acute lymphocytic leukemia
- Lymphoblastic leukemia
- ALL Leukemia in Remission
- Acute Lymphoblastic Leukemia in Remission
- Childhood Leukemia in Remission
- CML
- Chronic myelogenous leukemia
- Philadelphia chromosome positive leukemia
ICD-10 Codes:
- C9100: Acute lymphoblastic leukemia not having achieved remission
- C9101: Acute lymphoblastic leukemia, in remission
- C9210: Chronic myeloid leukemia, BCR/ABL-positive, not having achieved remission
Also known as:
- Cancer Chemotherapy
- Chemo treatment
- Oncology chemotherapy
- Cancer drug therapy
ICD-10 Codes:
- Z5111: Encounter for antineoplastic chemotherapy
Also known as:
- Lymphoblastic Lymphoma
- Lymphoma
- LL
- Precursor Lymphoblastic Lymphoma
- Lymphoblastic Lymphoma Cancer
ICD-10 Codes:
- C8350: Lymphoblastic (diffuse) lymphoma, unspecified site
What procedures does a Pediatric Hematologist-Oncologist like Dr. Sakamoto typically perform?
As a Pediatric Hematologist-Oncologist, Dr. Sakamoto performs a variety of medical procedures. This procedure information is derived from anonymized insurance claims and highlights the medical procedures most commonly performed by Dr. Sakamoto. It provides insight into the doctor’s areas of experience and expertise based on real-world patient encounters from the past two years, updated quarterly. Learn more about our claims-based healthcare methodology.
Also known as:
- Bone Marrow Biopsy and Aspiration
- Biopsy
- Bone Marrow Tests
- Bone Marrow Exam
- Bone Marrow Sample Collection
- Diagnostic Bone Marrow Procedure
CPT Codes:
- 38222: Diagnostic bone marrow; biopsy(ies) and aspiration(s)
Does Dr. Sakamoto accept my insurance?
Dr. Sakamoto accepts most major insurance plans. Important: Please call our office at (310) 206-3952 before your appointment to verify that your specific plan and network are accepted.
What insurance plans does Dr. Sakamoto accept in Palo Alto, CA?
Dr. Sakamoto in Palo Alto, CA accepts plans from many carriers. While this list is updated regularly, it is not a guarantee of coverage.
Top Insurances
Blue Shield of California
California Water Service Group
Cigna Group
CVS Health (formerly Aetna)
Hill Physicians Medical Group
Kaiser Permanente
OptumRx Administered Payer
Santa Cruz County
State of California
UnitedHealth Group
View All Insurances
Where is Dr. Sakamoto's office located?
What hospitals are Dr. Sakamoto affiliated with?
Castle Connolly Top Hospital
This doctor is affiliated with a Castle Connolly Top Hospital.
Dr. Sakamoto has admitting privileges at the following hospitals:
Recognitions
Awards
Standing Member, NIDDK-D Study Section for Training Grants and K award
Gift of Hope Award – Pediatric Cancer Research Foundation, 2008
Southern California Super Doctors
Top Women Southern California Super Doctors, 2011
Southern California Super Doctors 2008, 2009
Los Angeles Super Doctors, 2007
Chair, Myeloid Biology Subcommittee, American Society of Hematology, 2011
University of Colorado and Children's Hospital Denver – Brett Ely Visiting Professor in Pediatric Oncology,, 2011
Outstanding advances in cancer research award – Mendiburu Magic Foundation, 2010
Fernbach Distinguished Visiting Professor Lectureship, Texas Children, 2009
Junior Faculty Ross Research Award – Western Society for Pediatric Research, 1996
Young Investigator Award – American Society of Pediatric Hematology/Oncology, 1994
STOP Cancer Career Development award – UCLA Jonsson Comprehensive Cancer Center, 1992
Victor E. Stork Award – Children's Hospital of Los Angeles, 1988
Publications
The Multitargeted Receptor Tyrosine Kise Inhibitor Linifanib, 2011
CREB and leukemogenesis., 2011
Ribosomal protein S19 deficiency in zebrafish leads to developmental abnormalities, 2008
The role of CREB as a proto-oncogene in hematopoiesis and in acute myeloid leukemia, 2005
Ubistatins inhibit proteasome-dependent degradation by binding the ubiquitin chain, 2004
Development of protacs to target cancer-promoting proteins for ubiquitition and degradation, 2003
Protacs: Chimeric molecules that target proteins to the Skp1, 2001
Net1 stimulates R polymerase I transcription, 2001
MicroR-34b promoter hypermethylation induces CREB overexpression, 2013
Increased Abscess Formation and Defective Chemokine Regulation in CREB Transgenic Mice, 2013
Identification of somatic, 2013
Sox4 cooperates with CREB in myeloid transformation, 2012
The neutropenic diet... still ageless?, 2012
Editorial: Granulopoiesis versus monopoiesis, 2011
Tubacin suppresses proliferation and induces apoptosis of acute lymphoblastic leukemia cells, 2011
Increasing Diversity in Pediatric Hematology/Oncology, 2011
The Role of HDAC6 in Cancer
Self-Renewal of Acute Lymphocytic Leukemia Cells Is Limited by the Hedgehog Pathway Inhibitors, 2010
The Role of the Transcription Factor CREB in Immune Function, 2010
Germline CBL mutations cause developmental abnormalities, 2010
Targeting CREB for Cancer Therapy: Friend or Foe, 2010
Macroautophagy modulates cellular response to proteasome inhibitors in cancer therapy, 2010
Targeting steroid hormone receptors for ubiquitition and degradation in breast and prostate cancer, 2008
CREB is a critical regulator of normal hematopoiesis and leukemogenesis, 2008
Expression profile of CREB knockdown in myeloid leukemia cells., 2008
Expression of cyclic adenosine monophosphate response-element binding protein in acute leukemia, 2002
What is Dr. Sakamoto's NPI number?A National Provider Identifier (NPI) is a unique ID number that identifies doctors and healthcare providers nationwide.
Dr. Sakamoto's National Provider Identifier (NPI) number is 1437268539.
What common questions do patients ask about Dr. Sakamoto?
Here are answers to patients Frequently Asked Questions (FAQ’s) about Dr. Sakamoto